Adverum Biotechnologies, Inc.: cash_and_restricted_cash
| Value | {"amount": 129297000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2024-06-30) |
| Status | current |
| Entity | Adverum Biotechnologies, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:01:45.662009+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/634eb3b1-f2a6-4e80-9129-8775bf7b03b8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-24-036769Retrieved: 2026-08-19T15:01:45.662009+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001501756/cash-and-restricted-cash/2024-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/634eb3b1-f2a6-4e80-9129-8775bf7b03b8
History
- no predecessors — first report